SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T103. A total of 38 filers reported holding SAB BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,358 | -22.9% | 9,935 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $8,246 | +156.1% | 9,935 | +41.1% | 0.00% | +100.0% |
| Q1 2023 | $3,220 | -64.9% | 7,041 | -52.4% | 0.00% | -66.7% |
| Q4 2022 | $9,171 | +1.9% | 14,796 | +11.3% | 0.00% | -25.0% |
| Q3 2022 | $9,000 | -50.0% | 13,296 | 0.0% | 0.00% | -42.9% |
| Q2 2022 | $18,000 | – | 13,296 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First PREMIER Bank | 807,535 | $476 | 0.14% |
| Warberg Asset Management LLC | 370,370 | $218,518 | 0.03% |
| METEORA CAPITAL, LLC | 134,524 | $79,356 | 0.02% |
| INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | 149,774 | $88,352 | 0.02% |
| SILVER OAK SECURITIES, INCORPORATED | 51,941 | $31 | 0.01% |
| Veritable, L.P. | 506,513 | $298,792 | 0.01% |
| Shaolin Capital Management LLC | 236,621 | $140 | 0.00% |
| Elgethun Capital Management | 14,796 | $9,171 | 0.00% |
| LGL PARTNERS, LLC | 23,000 | $13,568 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 84,000 | $49,552 | 0.00% |